Four device companies in New Jersey underwent FDA inspections during the first quarter of 2026, according to the U.S. Food and Drug Administration (FDA).
This represented the lowest number of inspections per company type conducted by the FDA in New Jersey, accounting for 6% of all inspections in the state during that period.
Among New Jersey’s device sector companies, Accupac, LLC received the highest number of citations from the FDA in the first quarter of 2026.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | — | 4 | — |
| Blood and Blood Products | 2 | — | — |
| Compliance: Devices | 2 | 1 | — |
| Drug Quality Assurance | 4 | 2 | — |
| Food and Color Additives Petition Review | — | 1 | — |
| Food Composition, Standards, Labeling and Econ | 12 | — | — |
| Foodborne Biological Hazards | 30 | 16 | — |
| Human Cellular, Tissue, and Gene Therapies | 6 | — | — |
| Postmarket Assurance: Devices | 1 | 1 | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
